Amyl Therapeutics

Amyl Therapeutics develops Pan-Amyloid Immunotherapy, described as a groundbreaking approach designed to become a universal treatment for neurodegenerative diseases like Alzheimer's and Parkinson's. The therapy is designed to target toxic amyloid species and act at every stage of disease progression.